US Stock MarketDetailed Quotes

Inspire Medical Systems (INSP)

Watchlist
  • 42.345
  • +0.425+1.01%
Trading May 14 11:47 ET
1.22BMarket Cap9.62P/E (TTM)

Inspire Medical Systems (INSP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
291.69%12.85M
-10.19%116.98M
-24.16%52.47M
31.07%68.53M
3,541.03%2.68M
-175.65%-6.7M
428.32%130.25M
300.65%69.18M
1,337.14%52.28M
-101.53%-78K
Net income from continuing operations
-477.47%-11.29M
171.77%145.42M
286.36%136.09M
-46.30%9.93M
-136.68%-3.59M
129.91%2.99M
352.96%53.51M
138.60%35.22M
316.59%18.5M
181.94%9.79M
Depreciation and amortization
67.87%5.11M
113.08%13.96M
54.24%3.82M
98.76%3.68M
146.85%3.41M
262.81%3.04M
130.15%6.55M
203.30%2.48M
138.10%1.85M
109.86%1.38M
Deferred tax
--1.01M
---88.75M
----
----
----
--0
--0
----
----
----
Other non cash items
7.03%548K
39.16%2.11M
32.12%543K
20.77%535K
261.81%521K
-1.35%512K
-28.71%1.52M
-52.76%411K
-8.47%443K
-65.63%144K
Change In working capital
69.80%-13.11M
-131.72%-87.38M
-964.86%-26.85M
347.90%25.44M
-2.45%-42.56M
-776.24%-43.41M
7.53%-37.71M
115.60%3.11M
161.06%5.68M
-540.87%-41.54M
-Change in receivables
5,331.56%14.29M
-908.19%-26.23M
-194.61%-11.63M
400.22%29.72M
-477.89%-44.58M
-98.61%263K
91.39%-2.6M
78.80%-3.95M
-16.86%-9.9M
-67.54%-7.72M
-Change in inventory
-6.80%-20.94M
-40.97%-65.18M
72.28%-3.52M
-139.58%-20.14M
-117.97%-21.91M
-29.96%-19.61M
-110.16%-46.23M
-63.25%-12.69M
-59.42%-8.41M
-94.13%-10.05M
-Change in prepaid assets
-171.34%-1.26M
170.44%1.65M
77.25%3.76M
-110.19%-1.47M
87.28%-2.41M
13,507.69%1.77M
50.74%-2.34M
217.23%2.12M
1,612.09%14.45M
-489.35%-18.93M
-Change in payables and accrued expense
79.91%-5.19M
-82.36%2.38M
-187.80%-15.47M
81.76%17.34M
643.52%26.34M
-192.22%-25.83M
-16.83%13.47M
112.05%17.62M
165.02%9.54M
-174.42%-4.85M
Cash from discontinued investing activities
Operating cash flow
291.69%12.85M
-10.19%116.98M
-24.16%52.47M
31.07%68.53M
3,541.03%2.68M
-175.65%-6.7M
428.32%130.25M
300.65%69.18M
1,337.14%52.28M
-101.53%-78K
Investing cash flow
Cash flow from continuing investing activities
-624.34%-11.25M
118.96%21.45M
-416.88%-11.92M
88.69%-11.65M
728.51%46.56M
92.05%-1.55M
61.63%-113.12M
102.48%3.76M
28.61%-102.97M
14.81%5.62M
Capital expenditure reported
-15.69%-9.73M
----
----
----
----
---8.41M
----
----
----
----
Net PPE purchase and sale
----
1.59%-38.5M
-51.64%-10.66M
-30.37%-10.44M
27.40%-9M
28.12%-8.41M
-65.57%-39.12M
12.52%-7.03M
-14.58%-8.01M
-155.26%-12.39M
Net investment purchase and sale
-122.22%-1.52M
181.01%59.95M
-111.70%-1.26M
98.73%-1.21M
208.44%55.56M
187.43%6.85M
72.71%-74M
107.51%10.79M
30.81%-94.96M
84.75%18.01M
Cash from discontinued investing activities
Investing cash flow
-624.34%-11.25M
118.96%21.45M
-416.88%-11.92M
88.69%-11.65M
728.51%46.56M
92.05%-1.55M
61.63%-113.12M
102.48%3.76M
28.61%-102.97M
14.81%5.62M
Financing cash flow
Cash flow from continuing financing activities
91.47%-7.48M
-250.14%-183.45M
31.12%-48.31M
-616.46%-51.08M
-47.83%3.7M
-11,527.08%-87.76M
-475.58%-52.39M
-593.41%-70.14M
182.57%9.89M
-52.54%7.09M
Net issuance payments of debt
----
----
----
----
----
----
--0
----
----
----
Net common stock issuance
--0
-133.36%-175.02M
33.32%-50.01M
---50M
--0
---75.01M
---75M
---75M
--0
--0
Proceeds from stock option exercised by employees
-98.31%109K
-47.38%14.61M
144.09%2.4M
-97.56%347K
-39.33%5.43M
78.13%6.44M
-10.72%27.77M
-74.23%982K
254.21%14.23M
-43.73%8.95M
Net other financing activities
60.45%-7.59M
-346.16%-23.04M
-117.89%-694K
67.10%-1.43M
6.98%-1.73M
-573.88%-19.19M
69.90%-5.17M
127.86%3.88M
-740.12%-4.34M
-91.76%-1.86M
Cash from discontinued financing activities
Financing cash flow
91.47%-7.48M
-250.14%-183.45M
31.12%-48.31M
-616.46%-51.08M
-47.83%3.7M
-11,527.08%-87.76M
-475.58%-52.39M
-593.41%-70.14M
182.57%9.89M
-52.54%7.09M
Net cash flow
Beginning cash position
-30.19%104.81M
-19.07%150.15M
-23.50%112.85M
-43.13%106.93M
-69.28%53.88M
-19.07%150.15M
-57.98%185.54M
-55.29%147.51M
-59.74%188.04M
-60.32%175.42M
Current changes in cash
93.87%-5.88M
-27.67%-45.03M
-376.64%-7.76M
114.22%5.8M
319.22%52.94M
-869.17%-96.02M
86.23%-35.27M
101.94%2.8M
70.24%-40.8M
-49.32%12.63M
Effect of exchange rate changes
100.40%1K
-162.71%-310K
-65.66%-275K
-57.72%115K
1,120.00%102K
-17.76%-252K
-171.95%-118K
-178.67%-166K
633.33%272K
-400.00%-10K
End cash Position
83.61%98.93M
-30.19%104.81M
-30.19%104.81M
-23.50%112.85M
-43.13%106.93M
-69.28%53.88M
-19.07%150.15M
-19.07%150.15M
-55.29%147.51M
-59.74%188.04M
Free cash flow
120.67%3.12M
-13.88%78.48M
-32.73%41.81M
31.19%58.09M
49.38%-6.31M
-432.79%-15.11M
8,798.73%91.12M
573.10%62.15M
1,421.67%44.28M
-5,362.03%-12.47M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 291.69%12.85M-10.19%116.98M-24.16%52.47M31.07%68.53M3,541.03%2.68M-175.65%-6.7M428.32%130.25M300.65%69.18M1,337.14%52.28M-101.53%-78K
Net income from continuing operations -477.47%-11.29M171.77%145.42M286.36%136.09M-46.30%9.93M-136.68%-3.59M129.91%2.99M352.96%53.51M138.60%35.22M316.59%18.5M181.94%9.79M
Depreciation and amortization 67.87%5.11M113.08%13.96M54.24%3.82M98.76%3.68M146.85%3.41M262.81%3.04M130.15%6.55M203.30%2.48M138.10%1.85M109.86%1.38M
Deferred tax --1.01M---88.75M--------------0--0------------
Other non cash items 7.03%548K39.16%2.11M32.12%543K20.77%535K261.81%521K-1.35%512K-28.71%1.52M-52.76%411K-8.47%443K-65.63%144K
Change In working capital 69.80%-13.11M-131.72%-87.38M-964.86%-26.85M347.90%25.44M-2.45%-42.56M-776.24%-43.41M7.53%-37.71M115.60%3.11M161.06%5.68M-540.87%-41.54M
-Change in receivables 5,331.56%14.29M-908.19%-26.23M-194.61%-11.63M400.22%29.72M-477.89%-44.58M-98.61%263K91.39%-2.6M78.80%-3.95M-16.86%-9.9M-67.54%-7.72M
-Change in inventory -6.80%-20.94M-40.97%-65.18M72.28%-3.52M-139.58%-20.14M-117.97%-21.91M-29.96%-19.61M-110.16%-46.23M-63.25%-12.69M-59.42%-8.41M-94.13%-10.05M
-Change in prepaid assets -171.34%-1.26M170.44%1.65M77.25%3.76M-110.19%-1.47M87.28%-2.41M13,507.69%1.77M50.74%-2.34M217.23%2.12M1,612.09%14.45M-489.35%-18.93M
-Change in payables and accrued expense 79.91%-5.19M-82.36%2.38M-187.80%-15.47M81.76%17.34M643.52%26.34M-192.22%-25.83M-16.83%13.47M112.05%17.62M165.02%9.54M-174.42%-4.85M
Cash from discontinued investing activities
Operating cash flow 291.69%12.85M-10.19%116.98M-24.16%52.47M31.07%68.53M3,541.03%2.68M-175.65%-6.7M428.32%130.25M300.65%69.18M1,337.14%52.28M-101.53%-78K
Investing cash flow
Cash flow from continuing investing activities -624.34%-11.25M118.96%21.45M-416.88%-11.92M88.69%-11.65M728.51%46.56M92.05%-1.55M61.63%-113.12M102.48%3.76M28.61%-102.97M14.81%5.62M
Capital expenditure reported -15.69%-9.73M-------------------8.41M----------------
Net PPE purchase and sale ----1.59%-38.5M-51.64%-10.66M-30.37%-10.44M27.40%-9M28.12%-8.41M-65.57%-39.12M12.52%-7.03M-14.58%-8.01M-155.26%-12.39M
Net investment purchase and sale -122.22%-1.52M181.01%59.95M-111.70%-1.26M98.73%-1.21M208.44%55.56M187.43%6.85M72.71%-74M107.51%10.79M30.81%-94.96M84.75%18.01M
Cash from discontinued investing activities
Investing cash flow -624.34%-11.25M118.96%21.45M-416.88%-11.92M88.69%-11.65M728.51%46.56M92.05%-1.55M61.63%-113.12M102.48%3.76M28.61%-102.97M14.81%5.62M
Financing cash flow
Cash flow from continuing financing activities 91.47%-7.48M-250.14%-183.45M31.12%-48.31M-616.46%-51.08M-47.83%3.7M-11,527.08%-87.76M-475.58%-52.39M-593.41%-70.14M182.57%9.89M-52.54%7.09M
Net issuance payments of debt --------------------------0------------
Net common stock issuance --0-133.36%-175.02M33.32%-50.01M---50M--0---75.01M---75M---75M--0--0
Proceeds from stock option exercised by employees -98.31%109K-47.38%14.61M144.09%2.4M-97.56%347K-39.33%5.43M78.13%6.44M-10.72%27.77M-74.23%982K254.21%14.23M-43.73%8.95M
Net other financing activities 60.45%-7.59M-346.16%-23.04M-117.89%-694K67.10%-1.43M6.98%-1.73M-573.88%-19.19M69.90%-5.17M127.86%3.88M-740.12%-4.34M-91.76%-1.86M
Cash from discontinued financing activities
Financing cash flow 91.47%-7.48M-250.14%-183.45M31.12%-48.31M-616.46%-51.08M-47.83%3.7M-11,527.08%-87.76M-475.58%-52.39M-593.41%-70.14M182.57%9.89M-52.54%7.09M
Net cash flow
Beginning cash position -30.19%104.81M-19.07%150.15M-23.50%112.85M-43.13%106.93M-69.28%53.88M-19.07%150.15M-57.98%185.54M-55.29%147.51M-59.74%188.04M-60.32%175.42M
Current changes in cash 93.87%-5.88M-27.67%-45.03M-376.64%-7.76M114.22%5.8M319.22%52.94M-869.17%-96.02M86.23%-35.27M101.94%2.8M70.24%-40.8M-49.32%12.63M
Effect of exchange rate changes 100.40%1K-162.71%-310K-65.66%-275K-57.72%115K1,120.00%102K-17.76%-252K-171.95%-118K-178.67%-166K633.33%272K-400.00%-10K
End cash Position 83.61%98.93M-30.19%104.81M-30.19%104.81M-23.50%112.85M-43.13%106.93M-69.28%53.88M-19.07%150.15M-19.07%150.15M-55.29%147.51M-59.74%188.04M
Free cash flow 120.67%3.12M-13.88%78.48M-32.73%41.81M31.19%58.09M49.38%-6.31M-432.79%-15.11M8,798.73%91.12M573.10%62.15M1,421.67%44.28M-5,362.03%-12.47M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More